Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc.

NASDAQ:ORGO

Overview | Financials
Company Name Organogenesis Holdings Inc.
Symbol ORGO
Currency USD
Price 2.74
Market Cap 363,247,280
Dividend Yield 0%
52-week-range 1.96 - 4.705
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Gary S. Gillheeney Sr.
Website https://organogenesis.com

An error occurred while fetching data.

About Organogenesis Holdings Inc.

Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in

Related Stocks

NanoString Technologies, Inc. logo

NanoString Technologies, Inc.

NSTG

0.105 USD

Alector, Inc. logo

Alector, Inc.

ALEC

5.44 USD

Kymera Therapeutics, Inc. logo

Kymera Therapeutics, Inc.

KYMR

34.95 USD

Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

AVXL

4.55 USD

TransMedics Group, Inc. logo

TransMedics Group, Inc.

TMDX

137.98 USD

DocGo Inc. logo

DocGo Inc.

DCGO

3.08 USD

TG Therapeutics, Inc. logo

TG Therapeutics, Inc.

TGTX

16.48 USD

Financials

Numbers are in millions USD

Numbers are in millions USD